CMS: Medicare beneficiaries saved $3.9B on meds in 2013

CMS: medicare beneficiaries saved $3.9B on meds in 2013

(HealthDay)—In 2013, 4.3 million seniors and people with disabilities saved an estimated $3.9 billion on prescription drugs, an increase from the 2012 savings, according to a report published by the U.S. Department of Health and Human Services.

Since the enactment of the Affordable Care Act, 7.9 million seniors and people with disabilities have saved $9.9 billion on , equivalent to $1,265 per beneficiary. In 2013, 4.3 million beneficiaries saved $3.9 billion, equivalent to $911 per beneficiary, which represented an increase from 2012 when 3.5 million beneficiaries saved $2.5 billion, representing average savings of $706 per beneficiary.

As well as savings on prescription drugs, use of has increased among those with Medicare, with an estimated 37.2 million Medicare beneficiaries (including 26.5 million with traditional Medicare) taking advantage of at least one preventive service with no cost sharing in 2013. This included more than four million people who took advantage of the Annual Wellness Visit in 2013. These figures reflect an increase from 2012 when an estimated 34.1 million people with Medicare, including 26.1 with traditional Medicare, received one or more preventive benefit.

"Thanks to the Affordable Care Act, we saw a stronger Medicare program in 2013," Kathleen Sebelius, U.S. Secretary of Health and Human Services, said in a statement. "Seniors are saving billions of dollars on their needed medications and continuing to enjoy benefits that will lead to healthier lives and lower costs in the long run."

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Have a cold? Don't ask your doctor for antibiotics

Nov 26, 2014

Antibiotic resistance is a major threat to public health. Resistance makes it harder for physicians to treat infections and can increase the chance patients will die from an infection. What is more, the treatment ...

Powdered measles vaccine found safe in early clinical trials

Nov 25, 2014

A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published November 28 in the journal ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.